These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26298350)

  • 1. Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS).
    Patterson CC; Blankenberg S; Ben-Shlomo Y; Heslop L; Bayer A; Lowe G; Zeller T; Gallacher J; Young I; Yarnell J
    Int J Cardiol; 2015 Dec; 201():113-8. PubMed ID: 26298350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.
    Schnabel RB; Yin X; Larson MG; Yamamoto JF; Fontes JD; Kathiresan S; Rong J; Levy D; Keaney JF; Wang TJ; Murabito JM; Vasan RS; Benjamin EJ
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1728-33. PubMed ID: 23640499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D intake and risk of CVD and all-cause mortality: evidence from the Caerphilly Prospective Cohort Study.
    Guo J; Cockcroft JR; Elwood PC; Pickering JE; Lovegrove JA; Givens DI
    Public Health Nutr; 2017 Oct; 20(15):2744-2753. PubMed ID: 28803595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin and BNP are markers for subsequent non-ischaemic congestive heart failure: the Caerphilly Prospective Study (CaPS).
    Patterson CC; Blankenberg S; Ben-Shlomo Y; Heslop L; Bayer A; Lowe G; Zeller T; Gallacher J; Young I; Yarnell JWG
    Open Heart; 2018; 5(1):e000692. PubMed ID: 29531757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study.
    Peters SA; Woodward M; Rumley A; Tunstall-Pedoe HD; Lowe GD
    Eur J Prev Cardiol; 2017 Jan; 24(2):161-167. PubMed ID: 27798361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study.
    Bao X; Borné Y; Xu B; Orho-Melander M; Nilsson J; Melander O; Engström G
    Am Heart J; 2021 Apr; 234():81-89. PubMed ID: 33421373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S.
    Li J; Lee DH; Hu J; Tabung FK; Li Y; Bhupathiraju SN; Rimm EB; Rexrode KM; Manson JE; Willett WC; Giovannucci EL; Hu FB
    J Am Coll Cardiol; 2020 Nov; 76(19):2181-2193. PubMed ID: 33153576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
    Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
    J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
    Zakai NA; Katz R; Jenny NS; Psaty BM; Reiner AP; Schwartz SM; Cushman M
    J Thromb Haemost; 2007 Jun; 5(6):1128-35. PubMed ID: 17388967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
    Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
    Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
    Wannamethee SG; Lennon L; Shaper AG
    Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study.
    Yi SW; Lee SH; Hwang HJ; Yi JJ
    Atherosclerosis; 2017 Oct; 265():102-109. PubMed ID: 28881267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and inflammation in long-term cancer survivors: results from the adult population.
    Panova-Noeva M; Schulz A; Arnold N; Hermanns MI; Prochaska JH; Laubert-Reh D; Spronk HM; Blettner M; Beutel M; Pfeiffer N; Münzel T; Lackner KJ; Ten Cate H; Wild PS
    J Thromb Haemost; 2018 Apr; 16(4):699-708. PubMed ID: 29431889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort.
    Wu G; Li H; Fang Q; Jiang S; Zhang L; Zhang J; Hou X; Lu J; Bao Y; Xu A; Jia W
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2457-64. PubMed ID: 25189569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.